Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T Osato

Showing results (51-60 of 82) with videos related to

Pageof 9
Sort By:
Medical Microbiology and Immunology|August 1, 1995
Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infectionH Kimura, I Tsuge, S Imai, et al.
Anticancer Research|July 1, 1990
Suppression by protein kinase C inhibitors of tumor promoter enhancement of Epstein-Barr virus-induced growth transformationT Kinoshita, I Takahashi, E Kobayashi, et al.
Cancer|February 1, 1992
Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 moleculeM Abe, K Tasaki, K Tominaga, et al.
Virus Genes|April 1, 1991
An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNAK Takada, K Horinouchi, Y Ono, et al.
British Journal of Cancer|August 1, 1996
Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cellsM Sugiura, S Imai, M Tokunaga, et al.
Cancer|May 15, 1996
Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studiesY Harabuchi, S Imai, J Wakashima, et al.
Pathology, Research and Practice|December 1, 1993
Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphomaS Kon, T Sato, K Onodera, et al.
Lancet (London, England)|January 20, 1990
Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granulomaY Harabuchi, N Yamanaka, A Kataura, et al.
Virology|April 15, 1986
Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell linesS Koizumi, S Fujiwara, H Kikuta, et al.
The Tohoku Journal of Experimental Medicine|December 1, 1988
Establishment and characterization of an Epstein-Barr virus negative B-cell lymphoma cell line and successful heterotransplantationY Nozawa, M Abe, H Wakasa, et al.
Pageof 9

Showing results (51-60 of 82) with videos related to

Sort By:
Pageof 9
Medical Microbiology and Immunology|August 1, 1995
Intact antigen presentation for Epstein-Barr virus (EBV)-specific CTL by a lymphoblastoid cell line established from a patient with severe chronic active EBV infectionH Kimura, I Tsuge, S Imai, et al.
Anticancer Research|July 1, 1990
Suppression by protein kinase C inhibitors of tumor promoter enhancement of Epstein-Barr virus-induced growth transformationT Kinoshita, I Takahashi, E Kobayashi, et al.
Cancer|February 1, 1992
Characterization and comparison of two newly established Epstein-Barr virus (EBV)-negative and EBV-positive Burkitt's lymphoma cell lines. EBV-negative cell line with a low level of expression of ICAM-1 molecule and EBV-positive cell line with a high level of expression of ICAM-1 moleculeM Abe, K Tasaki, K Tominaga, et al.
Virus Genes|April 1, 1991
An Epstein-Barr virus-producer line Akata: establishment of the cell line and analysis of viral DNAK Takada, K Horinouchi, Y Ono, et al.
British Journal of Cancer|August 1, 1996
Transcriptional analysis of Epstein-Barr virus gene expression in EBV-positive gastric carcinoma: unique viral latency in the tumour cellsM Sugiura, S Imai, M Tokunaga, et al.
Cancer|May 15, 1996
Nasal T-cell lymphoma causally associated with Epstein-Barr virus: clinicopathologic, phenotypic, and genotypic studiesY Harabuchi, S Imai, J Wakashima, et al.
Pathology, Research and Practice|December 1, 1993
Detection of Epstein-Barr virus DNA and EBV-determined nuclear antigen in angioimmunoblastic lymphadenopathy with dysproteinemia type T cell lymphomaS Kon, T Sato, K Onodera, et al.
Lancet (London, England)|January 20, 1990
Epstein-Barr virus in nasal T-cell lymphomas in patients with lethal midline granulomaY Harabuchi, N Yamanaka, A Kataura, et al.
Virology|April 15, 1986
Production of human monoclonal antibodies against Epstein-Barr virus-specific antigens by the virus-immortalized lymphoblastoid cell linesS Koizumi, S Fujiwara, H Kikuta, et al.
The Tohoku Journal of Experimental Medicine|December 1, 1988
Establishment and characterization of an Epstein-Barr virus negative B-cell lymphoma cell line and successful heterotransplantationY Nozawa, M Abe, H Wakasa, et al.
Pageof 9